The kit measures accumulation of a protein that is a marker for the disease – a rare advance in tackling a condition
Video Duration 24 minutes 30 seconds 24:30 From: Inside Story Japanese and US pharmaceuticals publish results of a trial being hailed as
Under fire for approving a questionable drug for all Alzheimer’s patients, the Food and Drug Administration on Thursday greatly narrowed its previous
Such doctors face “a dilemma,” Dr. Karlawish said, “a moment when there’s no decision that resolves all the uncertainties and settles the
A newly approved drug to treat Alzheimer’s disease is expected to become a multibillion dollar expense for Medicare. By one projection, spending
Advocates Who Backed Approval Decry Cost Aducanumab had a rocky road to approval but had unwavering backing from the Alzheimer’s
June 9, 2021 — The FDA’s approval on Monday of a new drug to treat Alzheimer’s disease was met with both